Offer - Urjas Oil for just ₹ 1 X
Noculi B6 is an allopathic medicine The correct dosage of Noculi B6 depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Noculi B6 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Noculi B6 safe for pregnant women?
Noculi B6 is safe for pregnant women.
Is the use of Noculi B6 safe during breastfeeding?
Noculi B6 is safe for breastfeeding women.
What is the effect of Noculi B6 on the Kidneys?
Noculi B6 has very mild side effects on the kidneys.
What is the effect of Noculi B6 on the Liver?
The liver can be affected by Noculi B6. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Noculi B6 only after medical advice.
What is the effect of Noculi B6 on the Heart?
Information about safety of Noculi B6 for heart is not available since scientific research on this is yet to be done.
Noculi B6 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Noculi B6 unless your doctor advises you to do so -
Is this Noculi B6 habit forming or addictive?
Forming a habit of Noculi B6 has not been reported.
Interaction between Food and Noculi B6
Noculi B6 may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Noculi B6
Due to lack of research, there is no information about the side effects of taking Noculi B6 with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 800-801
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Urocit®-K (Potassium Citrate)